Please ensure Javascript is enabled for purposes of website accessibility

Why ShockWave Medical Stock Soared 30% in April

By Beth McKenna – May 8, 2019 at 7:57AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The medical device maker's stock has been on a tear since its March IPO.

What happened

Shares of medical device maker ShockWave Medical (SWAV 2.84%) popped 29.8% in April, according to data from S&P Global Market Intelligence. The S&P 500 index returned 4.1% last month.

The company describes itself as a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease. This technology uses sonic pressure waves, hence the company's name.

ShockWave's Intravascular Lithotripsy (IVL) device, which looks like a rectangular gadget with a wand attached.

Image source: ShockWave Medical.

So what

On April 24, ShockWave stock jumped 10.2% after the company announced that it would release first-quarter 2019 results on May 8. (Yes, today.) Shares continued to rise for the next couple of trading days.

The company didn't release any other notable news at about the time its stock got a nice boost, nor does it appear to have been the subject of any market-moving news. Thus, it seems the setting of the earnings release date was the primary catalyst for ShockWave stock's strong April performance. This announcement likely led more investors to discover the stock, as the company has only been publicly traded since early March.

SWAV Chart

Data by YCharts.

Here's how ShockWave stock has performed since its initial public offering (IPO). 

SWAV Chart

Data by YCharts.

Now what

Investors don't have long to wait for material news, as ShockWave Medical is scheduled to report its first-quarter 2019 results after the market close today.

Wall Street expects the company to post a loss per share of $0.52 on revenue of $5.7 million. 

 

Beth McKenna has no position in any of the stocks mentioned. The Motley Fool recommends ShockWave Medical. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ShockWave Medical Stock Quote
ShockWave Medical
SWAV
$286.87 (2.84%) $7.91

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
108%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.